Literature DB >> 3131717

Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.

C E Gauwerky1, J Hoxie, P C Nowell, C M Croce.   

Abstract

We have performed gene rearrangement studies on the leukemic blasts of a patient with acute pre-B-cell leukemia. The patient had a 5 year history of follicular lymphoma, which developed into acute pre-B-cell leukemia. The leukemic blasts revealed a karyotype with two translocations, t(8; 14) and t(14; 18), characteristic for Burkitt's lymphoma and follicular lymphoma. The cells are TdT positive, do not possess surface immunoglobulin, and they show immunoglobulin gene rearrangement. The mu heavy chain and kappa light chain constant (C mu and C kappa) loci are deleted, while the gamma and lambda light chain constant (C gamma and C lambda) region genes are rearranged. Both alleles of the heavy chain joining segment (JH) are rearranged on chromosome 14q+, one of them with the bcl-2 oncogene from chromosome 18. The breakpoint of the t(14; 18) translocation occurs in the major breakpoint cluster region in the 3' untranslated region of bcl-2. On chromosome 8 a c-myc rearrangement was mapped immediately 5' to the c-myc first exon in a region involved in sporadic Burkitt lymphoma. The data are consistent with our previous hypothesis on the evolution of B-cell malignancies: a rare pre-B cell develops a t(14; 18) translocation during immunoglobulin VDJ joining that results in an expansion of a follicular lymphoma clone carrying an activated bcl-2 gene. Within the clone of pre-B cells a second translocation, t(8; 14), occurs during heavy chain isotype switching that results in the deregulation of the c-myc involved in the translocation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131717

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  A 33-year-old man with an unclassifiable acute lymphoblastic leukemia.

Authors:  M H Kramer; J C Kluin-Nelemans; G C Beverstock; P M Kluin; R Bieger
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

2.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 3.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

4.  Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia.

Authors:  C Marosi; P Bettelheim; A Chott; U Köller; G Kreiner; G Steger; U Jäger; H Pirc-Danoewinata; K Lechner
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

5.  Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1.

Authors:  N Pathan; C Aime-Sempe; S Kitada; S Haldar; J C Reed
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

6.  CD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphoma.

Authors:  Philipp W Raess; Hao-Wei Wang; Svetlana D Pack; Elaine S Jaffe
Journal:  Histopathology       Date:  2019-08-22       Impact factor: 5.087

Review 7.  [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].

Authors:  M M Ott; H Horn; A Rosenwald; G Ott
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

8.  Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.

Authors:  S Casares; J M Rodríguez; A Martin; A Parrado
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

9.  Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene.

Authors:  C E Gauwerky; F G Haluska; Y Tsujimoto; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma.

Authors:  W Fiedler; H J Weh; W Zeller; C Fonatsch; J Hillion; C Larsen; B Wörmann; D K Hossfeld
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.